Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
37%
ALSO IN FMED
FMED
74
HOLDINGS
26%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus FMED)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
DANAHER CORP | 2.9% | 3.5% | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.5% | 4.5% | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 4.0% | 1.9% | 1.9% |
|
EDWARDS LIFESCIENCES CORP | 1.9% | 2.3% | 1.9% |
|
ELI LILLY & CO | 10.0% | 1.8% | 1.8% |
HRTS Overweight Relative to FMED
|
ELI LILLY & CO | 8.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.5% |
|
JOHNSON & JOHNSON | 4.9% |
 |
ASTRAZENECA PLC | 4.8% |
|
MERCK & CO. INC. | 4.2% |
|
GILEAD SCIENCES INC | 3.6% |
|
NOVARTIS AG | 3.6% |
|
ABBOTT LABORATORIES | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
|
ABBVIE INC | 3.0% |
HRTS Underweight Relative to FMED
 |
ARGENX SE ADR | -4.1% |
|
UCB SA | -3.7% |
|
COGENT BIOSCIENCES INC | -3.5% |
|
PENUMBRA, INC. | -2.9% |
|
VEEVA SYSTEMS INC-CLASS A | -2.8% |
|
ALNYLAM PHARMACEUTICALS INC | -2.6% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.3% |
 |
SARTORIUS STEDIM BIOTECH SA | -2.2% |
|
BOSTON SCIENTIFIC CORP | -2.0% |
|
MASIMO CORPORATION | -1.8% |